Key facts
- Notable investors include Eastend Ventures, Proserpine Capital Partners, Southern Angels, Virtca.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Fusetec
- ·The full record, as it builds
Funding rounds
No funding rounds for Fusetec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fusetec
Manufacturer of fully operable surgical training devices designed to simulate specific pathologies such as tumors, broken bones, and defective heart valves. The company platform designs and develops fully operable, soft tissue, anatomically accurate, surgical training models, ENT training devices, and medical training devices along with services such as soft tissue reproductions, commission development, and industrial prototyping, enabling students and surgeons to practice specific procedures.
- Sector
- Healthcare
- HQ
- Adelaide, Australia
- Founded
- 2017
- Employees
- 12
- Website
- fusetec.com.au/
- Ownership
- Privately Held (backing)
Fusetec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fusetec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fusetec in its N-PORT filings yet. We sweep new filings monthly.